Estrogen regulation of age and PTSD-associated changes in macrophage-induced neuroinflammation during HIV infection.
HIV 感染期间巨噬细胞诱导的神经炎症中雌激素对年龄和 PTSD 相关变化的调节。
基本信息
- 批准号:10707319
- 负责人:
- 金额:$ 21.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgeAgingAnti-Inflammatory AgentsAnti-Retroviral AgentsAntibodiesAntioxidantsAstrocytesAutomobile DrivingAutopsyAwardBindingBiologicalBiometryBiotechnologyCalciumClinical TrialsCoculture TechniquesCollecting CellComputer softwareConditioned Culture MediaCoupledCytometryDataDevelopmentDiagnosisDiseaseDisease ProgressionEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogen Replacement TherapyEstrogensExposure toFemaleFlow CytometryFutureGTP-Binding ProteinsGenderGenerationsGoalsHIVHIV InfectionsHIV-associated neurocognitive disorderHistorically Black Colleges and UniversitiesHumanIn VitroInflammationInflammatoryInstitutionKnowledgeLeadLearningLifeLife ExpectancyMacrophageMacrophage ActivationMass Spectrum AnalysisMeasuresMediatingMembraneMenopauseMentorsMicrogliaModelingMorphologyNeurocognitiveNeurocognitive DeficitNeurologicNeuronsNeuropathogenesisNeurotoxinsNuclear ReceptorsPathogenesisPatientsPersonsPhenotypePost-Traumatic Stress DisordersPostmenopausePremenopausePrincipal InvestigatorProcessProductionPropertyProteinsQuantitative Reverse Transcriptase PCRRBM5 geneRattusReceptor ActivationRecording of previous eventsRegulationReportingResearchResearch PersonnelRoleScienceSignal PathwaySignal TransductionSystemTNF geneTechniquesTestingTrainingViralWestern BlottingWomanagedaging populationantagonistantiretroviral therapybrain tissuecareercareer developmentclinical diagnosiscollegecomorbiditydata submissionexperiencehuman pluripotent stem cellimaging softwareinduced pluripotent stem cellmalemenmonocytenervous system disorderneuroAIDSneuroinflammationneuroprotectionneurotoxicitynovelnovel therapeutic interventionpsychiatric comorbidityreceptorreceptor expressionskill acquisitionskillssuccesssynergismtargeted treatmenttherapeutic targettraining opportunitytranslational research program
项目摘要
Project Summary/Abstract
30-50% of persons living with HIV still suffer from neurological co-morbidities, including HIV-associated
Neurocognitive Disorders (HAND) and Post-traumatic stress disorder (PTSD), despite the success of combined
Antiretroviral Therapy (cART). Persistent macrophage and microglia driven neuroinflammation is seen as a
common underlying factor in HAND and PTSD disease progression. The long-term objective of this research is
to understand the underling mechanisms that influence neuroinflammatory processes in neurological disorders
to target more specific endogenous signaling mechanisms for development of novel therapeutic approaches. In
this study we will explore estrogen signaling in macrophages and microglia as a possible therapeutic target. 17β-
estradiol, the most active form of estrogen, is reduced in postmenopausal women. Studies have shown that 17β-
estradiol is neuroprotective and its reduced expression may correlate with worse HIV and PTSD disease
progression. However, how changes in estrogen concentrations and its receptors may modulate HIV-induced
neurocognitive impairment in the post-menopausal women living with PTSD is unknown. Therefore, we
hypothesize that macrophage and microglia induced neuroinflammation will be suppressed by estrogen,
in an GPER dependent manner, in the aging female compared to males and pre-menopausal females
living with Post-traumatic stress disorder and HIV. To address this hypothesis, we will utilize 2 in vitro HIV
neuroinflammatory models: 1. A co-culture system composed of rat cortical neurons and human monocytes
derived macrophages isolated from PTSD donors and 2. A co-culture system of iMicroglia and iNeurons derived
from human pluripotent stem cells from healthy donors. iMicroglia and macrophages from pre and
postmenopausal women and aged matched men will be pretreated with various concentrations of estrogen prior
to HIVADA exposure to explore the following Specific Aims: 1) Evaluate estrogen’s ability to suppress HIV-
induced neuroinflammation in PTSD-hMDM and Microglia. 2) Evaluate the role of estrogen receptors in
HIV and PTSD-induced neuroinflammation. In this proposed award, we expect hMDMs from post-menopausal
female PTSD donors and iMicroglia will have increased HIV-induced neuroinflammation, which can be
suppressed by GPER activation. The principal investigator’s career goals are to lead an independent translation
research program while increasing diversity in the sciences at a Historically Black College and University
(HBCU). To accomplish this, the PI has developed a strong training plan that will expand her expertise in the
NeuroAIDS and PTSD field, increase her skillset in the generation of iPSC, flow cytometry, mass cytometry,
biostatistical analysis and generate data for future R awards. This training will be guided by the strong mentoring
committee of investigators from Spelman College and neighboring Research 1 institutions. With success of this
project, we will elucidate the role of estrogen signaling as a potential endogenous targeted therapeutic avenue
for persons living with HAND, PTSD and other neuroinflammatory disorders.
项目摘要/摘要
30%-50%的艾滋病毒携带者仍然患有神经系统共病,包括与艾滋病毒相关的
神经认知障碍(手)和创伤后应激障碍(PTSD),尽管联合治疗取得成功
抗逆转录病毒疗法(CART)持续性巨噬细胞和小胶质细胞引起的神经炎被视为
手部和创伤后应激障碍疾病进展的共同潜在因素。这项研究的长期目标是
了解影响神经性疾病中神经炎性过程的潜在机制
针对更具体的内源性信号机制,开发新的治疗方法。在……里面
在本研究中,我们将探索巨噬细胞和小胶质细胞中的雌激素信号,作为可能的治疗靶点。17β-
雌激素是雌激素中最活跃的形式,在绝经后的女性中会减少。研究表明,17β-
雌二醇具有神经保护作用,其表达减少可能与更严重的艾滋病毒和创伤后应激障碍相关
进步。然而,雌激素浓度及其受体的变化可能如何调节艾滋病毒诱导的
患有创伤后应激障碍的绝经后妇女的神经认知损害尚不清楚。因此,我们
假设巨噬细胞和小胶质细胞引起的神经炎症将被雌激素抑制,
在GPER依赖的方式下,在老年女性与男性和绝经前女性相比
患有创伤后应激障碍和艾滋病毒。为了解决这一假设,我们将使用2个体外艾滋病毒
神经炎性模型:1.大鼠皮层神经元与人单核细胞共培养体系
创伤后应激障碍供者来源的巨噬细胞及2.小胶质细胞与神经细胞来源的共培养体系
来自健康捐赠者的人类多能干细胞。前和后的小胶质细胞和巨噬细胞
绝经后妇女和匹配的老年男子将在治疗前接受不同浓度的雌激素。
以探索以下具体目标:1)评估雌激素抑制艾滋病毒的能力-
诱导PTSD-HMDM和小胶质细胞的神经炎症。2)评估雌激素受体在
艾滋病毒和创伤后应激障碍引起的神经炎症。在这个提议的奖项中,我们期望来自绝经后的hmdm。
女性创伤后应激障碍捐赠者和小胶质细胞将增加艾滋病毒诱导的神经炎症,这可能是
被GPER激活抑制。首席调查员的职业目标是领导独立翻译
在一所历史悠久的黑人学院和大学增加科学多样性的同时进行研究计划
(HBCU)。为了实现这一目标,私家侦探制定了一项强有力的培训计划,以扩大她在
神经艾滋病和创伤后应激障碍领域,提高了她在IPSC、流式细胞术、质量细胞术、
生物统计分析,并为未来的R奖生成数据。本次培训将在强有力的指导下进行
来自斯佩尔曼学院和邻近研究机构的调查委员会。随着这件事的成功
项目中,我们将阐明雌激素信号作为潜在的内源性靶向治疗途径的作用。
适用于手部、创伤后应激障碍和其他神经炎症性疾病患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kimberly S. Williams其他文献
Neuroinflammation and EIF2 signaling persist in an HiPSC tri-culture model of HIV infection despite antiretroviral treatment
尽管进行了抗逆转录病毒治疗,但 HIV 感染的 HiPSC 三培养模型中神经炎症和 EIF2 信号传导仍然存在
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Sean K. Ryan;Michael V. Gonzalez;James P Garifallou;F. C. Bennett;Kimberly S. Williams;H. Hakonarson;S. Anderson;K. Jordan - 通讯作者:
K. Jordan
NEUROTROPHIN-CHEMOKINE RECEPTOR INTERACTIONS ON MACROPHAGES REGULATE HIV NEUROPATHOGENESIS
- DOI:
- 发表时间:
2015-05 - 期刊:
- 影响因子:4
- 作者:
Kimberly S. Williams - 通讯作者:
Kimberly S. Williams
Kimberly S. Williams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kimberly S. Williams', 18)}}的其他基金
Estrogen regulation of age and PTSD-associated changes in macrophage-induced neuroinflammation during HIV infection.
HIV 感染期间巨噬细胞诱导的神经炎症中雌激素对年龄和 PTSD 相关变化的调节。
- 批准号:
10572654 - 财政年份:2022
- 资助金额:
$ 21.1万 - 项目类别:
Neurotrophin- Chemokine Receptor Interactions Regulate Macrophage Activation
神经营养蛋白-趋化因子受体相互作用调节巨噬细胞激活
- 批准号:
8542294 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
Neurotrophin- Chemokine Receptor Interactions Regulate Macrophage Activation
神经营养蛋白-趋化因子受体相互作用调节巨噬细胞激活
- 批准号:
8659199 - 财政年份:2013
- 资助金额:
$ 21.1万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 21.1万 - 项目类别:
Research Grant














{{item.name}}会员




